Advanced oral therapies for colorectal cancer via nanomedicine and microbiota modulation
- 22 November 2025
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 228, 115741
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82370860)
- Fundamental Research Funds for the Central Universities (YJ202412)
- National University's Basic Research Foundation of China
- Sichuan University
- China Scholarship Council
- Fonds De La Recherche Scientifique - FNRS (WELBIO-CR-2022 S\u201301)
- Science and Technology Department of Sichuan Province (24YFHZ0326)
This publication has 247 references indexed in Scilit:
- An Oral Nanovaccine Secreted by Genetically Engineered and Ultrasound‐Responsive Bacteria for Colon Cancer ImmunotherapyAdvanced Functional Materials, 2024
- Chimeric Antigen Receptor T Cells Targeting CD19 and GCC in Metastatic Colorectal CancerJAMA Oncology, 2024
- The challenge and opportunity of gut microbiota‐targeted nanomedicine for colorectal cancer therapyiMeta, 2024
- Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer TherapyAdvanced Materials, 2023
- Development of a Clinically Viable Strategy for Nanoparticle‐Based Photodynamic Therapy of Colorectal CancerAdvanced Therapeutics, 2023
- Diagnosis and Treatment of Metastatic Colorectal CancerJAMA, 2021
- Prebiotics‐Encapsulated Probiotic Spores Regulate Gut Microbiota and Suppress Colon CancerAdvanced Materials, 2020
- Polymeric Nanoparticles with ROS‐Responsive Prodrug and Platinum Nanozyme for Enhanced Chemophotodynamic Therapy of Colon CancerAdvanced Science, 2020
- Targeting siRNA in colorectal cancer therapy: Nanotechnology comes into viewJournal of Cellular Physiology, 2019
- ROS‐Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer TherapyAdvanced Materials, 2017